This life sciences stock has a secret weapon and AI will only make it more valuable
IQVIA, with its vast trove of health information, is at the center of drug development, providing data, tools and services…
IQVIA, with its vast trove of health information, is at the center of drug development, providing data, tools and services…
Nordisk is partnering with OpenAI to “bring new and better treatment options to patients faster,” the Danish drugmaker said Tuesday.…
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Nvidia CEO Jensen Hwang delivers the keynote address at the company's annual GTC developer conference at the SAP Center in…
Jim Cramer explained Tuesday morning why the Investment Club is trying to strike a delicate balance with its moves during…
Jim Cramer's advice to investors dealing with the fallout from the US-Israeli attack on Iran: be selective. With stocks initially…
A startup widely known as “ChatGPT for doctors” raised a new round of funding that values the company at $12…
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…